11-Feb-2025 5:20 AM CST - Yahoo Finance DXCM Q4 Earnings to Reflect Market Expansion & Stelo Impact? DexCom Q4 results are likely to reflect strong growth on the back of U.S. sales expansion, global gains and Stelo traction, driving momentum and market expansion into 2025.
10-Feb-2025 12:23 PM CST - Investing BofA maintains Buy on DexCom stock with $90 target BofA Securities maintained a Buy rating on DexCom (NASDAQ:DXCM) shares, with a steady price target of $90.00. The firm's analysts suggest the current market movement presents an appealing opportunity for investors to purchase shares,
10-Feb-2025 9:40 AM CST - Business Insider BofA says use DexCom's stock move as buying opportunity DexCom (DXCM) shares are down on Monday morning on a notification that some customers are receiving 30 days of supplies instead of 90 days amid
6-Feb-2025 9:01 AM CST - Zacks DexCom (DXCM) Q4 Earnings Preview: What's in the Cards? Wall Street expects flat earnings compared to the year-ago quarter on higher revenues when DexCom (DXCM) reports results for the quarter ended December 2024. While this widely-known consensus outlook is important in gauging the company's earnings picture,
6-Feb-2025 8:30 AM CST - The Motley Fool Should You Buy DexCom Stock Before Feb. 13? DexCom (NASDAQ: DXCM) is a healthcare company that makes continuous glucose monitoring (CGM) devices, which help people track glucose levels. However, the rising popularity of GLP-1 drugs, which are highly effective in helping people lose weight and also reduce the risk of becoming diabetic,
3-Feb-2025 12:05 PM CST - Fintel Redburn Atlantic Upgrades DexCom (DXCM) Fintel reports that on February 3, 2025, Redburn Atlantic upgraded their outlook for DexCom (NasdaqGS:DXCM) from Neutral to Buy. Analyst Price Forecast Suggests 14.60% Upside As of January 28, 2025, the average one-year price target for DexCom is $99.
3-Feb-2025 3:27 AM CST - MSN Redburn raises DexCom stock rating to buy, price target to $115 DexCom (NASDAQ:DXCM) shares received an optimistic update from Redburn-Atlantic, with analyst Issie Kirby (NYSE:KEX) upgrading the stock from Neutral to Buy and increasing the price target to $115 from the previous $85.
Latest DXCM Trades by Congress Members
31-DEC-2024 - Kevin Hern, OK (District 1) sold between $50,001 and $500,000.
11-Feb-2025 5:20 AM CST - Yahoo Finance DXCM Q4 Earnings to Reflect Market Expansion & Stelo Impact? DexCom Q4 results are likely to reflect strong growth on the back of U.S. sales expansion, global gains and Stelo traction, driving momentum and market expansion into 2025.
10-Feb-2025 12:23 PM CST - Investing BofA maintains Buy on DexCom stock with $90 target BofA Securities maintained a Buy rating on DexCom (NASDAQ:DXCM) shares, with a steady price target of $90.00. The firm's analysts suggest the current market movement presents an appealing opportunity for investors to purchase shares,
10-Feb-2025 9:40 AM CST - Business Insider BofA says use DexCom's stock move as buying opportunity DexCom (DXCM) shares are down on Monday morning on a notification that some customers are receiving 30 days of supplies instead of 90 days amid
6-Feb-2025 9:01 AM CST - Zacks DexCom (DXCM) Q4 Earnings Preview: What's in the Cards? Wall Street expects flat earnings compared to the year-ago quarter on higher revenues when DexCom (DXCM) reports results for the quarter ended December 2024. While this widely-known consensus outlook is important in gauging the company's earnings picture,
6-Feb-2025 8:30 AM CST - The Motley Fool Should You Buy DexCom Stock Before Feb. 13? DexCom (NASDAQ: DXCM) is a healthcare company that makes continuous glucose monitoring (CGM) devices, which help people track glucose levels. However, the rising popularity of GLP-1 drugs, which are highly effective in helping people lose weight and also reduce the risk of becoming diabetic,
3-Feb-2025 12:05 PM CST - Fintel Redburn Atlantic Upgrades DexCom (DXCM) Fintel reports that on February 3, 2025, Redburn Atlantic upgraded their outlook for DexCom (NasdaqGS:DXCM) from Neutral to Buy. Analyst Price Forecast Suggests 14.60% Upside As of January 28, 2025, the average one-year price target for DexCom is $99.
3-Feb-2025 3:27 AM CST - MSN Redburn raises DexCom stock rating to buy, price target to $115 DexCom (NASDAQ:DXCM) shares received an optimistic update from Redburn-Atlantic, with analyst Issie Kirby (NYSE:KEX) upgrading the stock from Neutral to Buy and increasing the price target to $115 from the previous $85.